Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/18—Applying electric currents by contact electrodes
  • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
  • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
  • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
  • A61N1/36128—Control systems
  • A61N1/36132—Control systems using patient feedback
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/18—Applying electric currents by contact electrodes
  • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
  • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
  • A61N1/372—Arrangements in connection with the implantation of stimulators
  • A61N1/37211—Means for communicating with stimulators
  • A61N1/37235—Aspects of the external programmer
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/18—Applying electric currents by contact electrodes
  • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
  • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
  • A61N1/372—Arrangements in connection with the implantation of stimulators
  • A61N1/37211—Means for communicating with stimulators
  • A61N1/37235—Aspects of the external programmer
  • A61N1/37241—Aspects of the external programmer providing test stimulations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/18—Applying electric currents by contact electrodes
  • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
  • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
  • A61N1/372—Arrangements in connection with the implantation of stimulators
  • A61N1/37211—Means for communicating with stimulators
  • A61N1/37235—Aspects of the external programmer
  • A61N1/37247—User interfaces, e.g. input or presentation means

Definitions

• 61/491,092 filed May 27, 2011, 61/693,866 (“the '866 application”) filed August 28, 2012, 61/699,1 15 (“the ' 1 15 application”) filed September 10, 2012, 61/699,135 (“the ⁇ 35 application”) filed September 10, 2012, and 61/753,232 (“the '232 application”) filed January 16, 2013.
• the present invention relates to a system and method for generating and outputting a clinical response data map in which recorded clinical response data are graphically represented in correlation with stimulation program settings for a leadwire, e.g., of a Deep Brain Stimulation (DBS) device, a Spinal Cord Stimulation (SCS) device, or other stimulation device.
• a leadwire e.g., of a Deep Brain Stimulation (DBS) device, a Spinal Cord Stimulation (SCS) device, or other stimulation device.
• DBS Deep Brain Stimulation
• SCS Spinal Cord Stimulation
• DBS deep brain stimulation
• SCS spinal cord stimulation
• Occipital NS therapy Trigemenal NS therapy
• Vagus NS therapy peripheral field stimulation therapy
• sacral root stimulation therapy or other such therapies.
• DBS can include stimulation of the thalamus or basal ganglia and may be used to treat disorders such as essential tremor, Parkinson's disease (PD), and other physiological disorders, including psychiatric disorders.
• PD Parkinson's disease
• DBS can also be useful for traumatic brain injury and stroke.
• DBS is also used for treating dystonia, epilepsy, and obsessive-compulsive disorder.
• the stimulation parameters, electrode geometries, or electrode locations that are best suited for existing or future uses of DBS also are unclear.
• a neurosurgeon can select a target region within the patient anatomy, e.g., within the brain for DBS, an entry point, e.g., on the patient's skull, and a desired trajectory between the entry point and the target region.
• the entry point and trajectory are typically carefully selected to avoid intersecting or otherwise damaging certain nearby critical structures or vasculature.
• a stimulation electrode leadwire used to provide the stimulation to the relevant anatomical region is inserted along the trajectory from the entry point toward the target region.
• the stimulation electrode leadwire typically includes multiple closely-spaced electrically independent stimulation electrode contacts.
• the target anatomical region can include tissue that exhibit high electrical conductivity.
• a stimulation parameter can include a current amplitude or voltage amplitude, which can be the same for all of the electrodes of the leadwire, or which can vary between different electrodes of the leadwire.
• the applied amplitude setting results in a corresponding current in the surrounding fibers, and therefore a corresponding voltage distribution in the surrounding tissue.
• the complexity of the inhomogeneous and anisotropic fibers makes it difficult to predict the particular volume of tissue influenced by the applied stimulation.
• a treating physician typically would like to tailor the stimulation parameters (such as which one or more of the stimulating electrode contacts to use, the stimulation pulse amplitude, e.g., current or voltage depending on the stimulator being used, the stimulation pulse width, and/or the stimulation frequency) for a particular patient to improve the effectiveness of the therapy.
• Parameter selections for the stimulation can be achieved via tedious and variable trial-and-error, without visual aids of the electrode location in the tissue medium or computational models of the volume of tissue influenced by the stimulation. Such a method of parameter selection is difficult and time-consuming and, therefore, expensive. Moreover, it may not necessarily result in the best possible therapy.
• the leadwire can include cylindrically symmetrical electrodes, which, when operational, produce approximately the same electric values in all positions at a similar distance from the electrode in any plane that cuts through the electrode.
• the leadwire can include directional electrodes that produce different electrical values depending on the direction from the electrode.
• the leadwire can include multiple separately controllable electrodes arranged cylindrically about the leadwire at each of a plurality of levels of the leadwire. Each electrode may be set as an anode or cathode in a bipolar configuration or as a cathode, with, for example, the stimulator casing being used as ground, in a monopolar arrangement.
• a leadwire for tissue stimulation e.g., DBS
• the clinical standard of care is often to perform a monopolar review (MPR) upon activation of the leadwire in order to determine the efficacy and side-effect thresholds for all electrodes on the leadwire, on an electrode-by-electrode basis.
• MPR monopolar review
• the MPR can inform the selection of a first clinical program (parameters for stimulation) for treating a patient.
• Example systems for programming a leadwire for tissue stimulation display a graphical representation of an area within which it is estimated that there is or could be tissue activation, referred to herein as a volume of activation (VOA), that results from input stimulation parameters.
• VOA volume of activation
• the VOA can be calculated as a region outside of which stimulation is estimated to be unlikely.
• the VOA can be displayed relative to an image or model of a portion of the patient's anatomy.
• Generation of the VOA may be based on Neural Element Models such as a model of fibers, e.g., axons, and a voltage distribution about the leadwire and on detailed processing thereof. Performing such processing to provide a VOA preview in real-time response to a clinician's input of parameters is not practical because of the significant required processing time. Therefore, conventional systems pre-process various stimulation parameter settings to determine which axons are activated by the respective settings.
• Those systems also provide interfaces via which to input selections of the stimulation parameters and notes concerning therapeutic and/or side effects of stimulations associated with graphically represented VOAs.
• the systems also allow user input of, or automatically determine, a target stimulation region, e.g., within or encompassing one or more defined anatomic structures, or allow user input of, or automatically determine, a target defined anatomic structure, which target region or structure is targeted for stimulation.
• Example embodiments of the present invention provide a system and method for providing a therapy effect history map.
• Example embodiments of the present invention provide a system and method for inputting therapy effect information in relation to a therapy effect map.
• Example embodiments of the present invention provide a system and method for selecting therapy parameters using an interface that includes a map, which map includes a plurality of positions corresponding to respective therapy parameters which may be selected by the user. According to an example embodiment, the map is also a therapy effect map.
• the therapy effect history map is integrated with a system for parameter selection, which selected parameters are, according to an example embodiment, usable for programming an implanted leadwire, using the same interface and/or system in which the therapy effect history map is provided.
• the therapy effect history map is provided as a stand-alone program and/or system, separate from the application used for programming the leadwire.
• a system is configured to obtain information representing one or more effects of a stimulation therapy.
• the system is configured to receive information concerning therapeutic and/or adverse side effects of a stimulation therapy.
• the information is received in connection with particular stimulation parameters and the system stores the effects information in association with the stimulation parameters to which the information indicates the effects relate.
• the system generates, and outputs in a user interface, a map whose positions correspond to different respective stimulation parameter sets with respect to, for example, two (or more) predefined or user-selected parameters.
• the map is a two- dimensional map, of which a first axis corresponds to position along a leadwire, e.g., a particular actual or virtual electrode, and a second axis corresponds to stimulation amplitude.
• a virtual electrode is a leadwire position with which a stimulation is associated, as though the stimulation was produced by an electrode at that location, when, instead, the stimulation is actually produced by activation of a combination of a plurality of electrodes at other locations.
• the system outputs a, for example, two dimensional model of the leadwire as or alongside an edge of the map to represent or complements the values of the corresponding axis.
• the model includes representations of electrodes of the leadwire.
• the system populates the map with the received therapy effects information, different items of the information, associated with different combinations of the parameters to which the map positions correspond, being used for populating the different positions of the map.
• the system generates a graphical marking including one or more variable visual characteristics, where the selected value(s) of the characteristic(s) indicates a respective aspect of the information associated with the map position which the graphical marking populates.
• a non-exhaustive list of example characteristics includes color, hatching, transparency, size, thickness, and shape.
• the system generates one or more revised values for the effects based on a combination of the effects information recorded in association with the parameters to which the map position corresponds.
• each of one or more of the records includes one or more respective scores, with the system calculating a score based on a combination, e.g., average, of the scores of the different records.
• the system calculates a new score, e.g., the average score of 2.5, and populates the map position corresponding the electrode and amplitude combination with a graphical marking representative of the calculated combinatory score.
• the system uses the latest recorded effects information for a particular stimulation parameter set to which a map position corresponds for populating the map position.
• the obtained records associated with the parameters corresponding to a single map location can correspond to a plurality of patients who have been subjected to a stimulation at that parameter set; a plurality of indications, symptoms, and/or diseases for which different stimulations have been conducted for one or more patients; and/or a plurality of stimulation sessions conducted at different times for one or more patients.
• the system provides a user interface component via which to receive user input of criteria by which to limit the scope of the stimulations whose information are used for populating the map.
• the user can limit the population to information corresponding to stimulations associated with particular patients, e.g., a current patient being treated or patients having certain characteristics (e.g., those of a certain height, weight, gender, taking certain medications, etc.), particular diseases, particular times, e.g., the last 5 months, and/or particular sessions, e.g., last 5 sessions.
• certain characteristics e.g., those of a certain height, weight, gender, taking certain medications, etc.
• particular diseases e.g., the last 5 months
• particular sessions e.g., last 5 sessions.
• a combination of filter parameters can be used.
• subsequent to an initial display of the graphical markings using no or few filter parameters the user can add filter parameters to gradually remove some of the markings. This can be useful because the user may want to see how various criteria impact stimulation score.
• the graphical marking includes a plurality of parts, each corresponding to a different aspect of the information associated with the stimulation settings to which the map position populated by the graphical marking corresponds.
• received information includes an adverse side effect score and a therapeutic effect score
• the graphical marking includes a first part representative of the side effect score and a second part representative of the therapeutic effect score.
• different scores may be obtained, and accordingly represented by respective parts of the graphical marking, for different adverse side effects, e.g., parasthesia, dyskenisia, etc., and different therapeutic effects, e.g., positive effects with respect to rigidity, tremor, etc.
• the system calculates and represents as a respective part of the marking an overall score based on a combination of both adverse side effect information and therapeutic effect information, the adverse side effect score adversely affecting the overall score and the therapeutic effect score positively affecting the overall score.
• the different parts of the graphical marking are concentrically arranged, one within the other, with different bands about the center dedicated for representing different types of information. That records corresponding to a particular map location include information regarding only one of the types to which the bands correspond can occur.
• the band(s) corresponding to the missing information is left devoid of any of the graphical characteristics used for representing the information. For example, a pure black and solid band can be used where there is no information to represent for the particular band.
• the concentrically arranged marking can be a circle, square, or any other shape.
• An example embodiment of the present invention is directed to one or more processors, which can be implemented using any conventional processing circuit and device or combination thereof, e.g., a Central Processing Unit (CPU) of a Personal Computer (PC) or other workstation processor, to execute code provided, e.g., on a hardware computer- readable medium including any conventional memory device, to perform any of the methods described herein, alone or in combination, and to generate any of the user interface displays described herein, alone or in combination.
• the one or more processors can be embodied in a server or user terminal or combination thereof.
• the user terminal can be embodied, for example, as a desktop, laptop, hand-held device, Personal Digital Assistant (PDA), television set-top Internet appliance, mobile telephone, smart phone, iPad etc., or as a combination of one or more thereof.
• PDA Personal Digital Assistant
• described features can be integrated with and be embodiment as a clinician programmer terminal, e.g., as referred to in the '330, '312, '340, '343, and '314 applications. Additionally, some of the described methods can be performed by a processor on one device or terminal and using a first memory, while other methods can be performed by a processor on another device and using, for example, a different memory.
• the features can be embodied in an application for a smartphone and/or iPad, for example.
• the memory device can include any conventional permanent and/or temporary memory circuits or combination thereof, a non-exhaustive list of which includes Random Access Memory (RAM), Read Only Memory (ROM), Compact Disks (CD), Digital Versatile Disk (DVD), and magnetic tape.
• RAM Random Access Memory
• ROM Read Only Memory
• CD Compact Disks
• DVD Digital Versatile Disk
• An example embodiment of the present invention is directed to one or more hardware computer-readable media, e.g., as described above, on which are stored instructions executable by a processor to perform the methods and/or provide the user interface features described herein.
• An example embodiment of the present invention is directed to a method, e.g., of a hardware component or machine, of transmitting instructions executable by a processor to perform the methods and/or provide the user interface features described herein.
• system features draw upon data, such as clinical effects data for producing the therapy effect history map, and/or produce such data, where such data is obtained from and/or stored to a data store.
• the data store can be located, for example, on a simulator device, a computer used for inputting such data, a patient remote control usable by the patient for adjusting stimulation parameters of an implanted stimulation leadwire, a central local database, or a cloud database.
• the data store stores data of a plurality of patients, the data of the plurality of patients being used for generating a single therapy effect history map.
• the system generates a therapy effect history map for a particular patient selectively using only the clinical history data of only the respective patient.
• FIG. 1 is a screenshot of a graphical user interface including a clinical response map, according to an example embodiment of the present invention.
• FIG. 2 is a screenshot of a graphical user interface including a clinical response map and including a control by which to bring up an extended menu of effect types, according to an example embodiment of the present invention.
• FIG. 3 is a screenshot showing an extended menu of effect types, according to an example embodiment of the present invention.
• FIG. 4 is a screenshot showing a clinical response map overlapping a representation of an anatomical structure and including a circular indicator of stimulation magnitude, according to an example embodiment of the present invention.
• FIG. 5 shows a report including a column of graphical clinical effects representations generatable by a processor based on clinical effects data, according to an example embodiment of the present invention.
• FIG. 6 shows a system according to an example embodiment of the present invention.
• FIG. 1 shows an example user interface screen 100 generated and output according to an example embodiment of the present invention.
• the screen 100 includes a clinical response map 102 including a first axis 104 corresponding to leadwire position or electrode number and a second axis 106 corresponding to stimulation amplitude. Positions in the map therefore correspond to respective stimulations, each associated with activation of a respective actual or virtual electrode at a particular stimulation amplitude.
• the system displays at respective ones of those positions respective graphical markings 108 (only one is labeled in FIG. 1 for purposes of clarity).
• the markings include a ring 108a about a center region 108b.
• the ring 108a represents an adverse side effect score and the center region 108b corresponds to a therapeutic effect score.
• the ring 108a and the center region 108b are graphically demarcated from each other, for example by use of different colors and/or hatching.
• the center region 108b is filled (where a respective score is available) using a blue color and the ring 108a is filled (wherein a respective score is available) using a yellow color.
• the appropriately colored ring 108a is displayed about an empty center region 108b, e.g., the center region 108b being black or whichever other background color is used for the map 102.
• the appropriately colored center region 108b is displayed without any ring 108a surrounding the center region 108b or with only a ring outline where the ring 108a would otherwise be displayed, the ring outline being black filled, or filled with whichever other background color is used for the map 102.
• the center regions 108b of different ones of the graphical markings 108 are differently saturated with the selected color, i.e., their transparencies differ, in correspondence with differences in their respective scores.
• the center regions 108b of the graphical markings 108 at those map positions associated with high therapeutic effect scores are highly saturated with the therapeutic effect color (with low transparency), and the center regions 108b of the graphical markings 108 at those map positions associated with low therapeutic effect scores are less saturated with the therapeutic effect color (with higher transparency).
• the degrees of saturation and transparency are many for representing many different scores.
• the rings 108a of different ones of the graphical markings 108 are of different thicknesses in correspondence with differences in their respective scores.
• the ring 108a of the graphical markings 108 at those map positions associated with high adverse side effect scores are thick, and the rings 108a of the graphical markings 108 at those map positions associated with low adverse effect scores thinner.
• the degrees of thickness are many for representing many different scores.
• the user interface screen 100 includes a user-selectable criteria selector control 110, which can be selected for input of filter criteria for filtering the records used for generating the map 102.
• FIG. 1 shows that all records are being used. (This may be limited to certain default filter criteria in any case.
• the system may be set to limit the used records to those associated to a patient currently being programmed.)
• the system responsive to selection of the control 110, the system provides input fields in which a user can input filter criteria, such as those described above, for limiting the records being used for the generation of the map.
• the displayed graphical markings 108 are selectable, in response to which selection, the system outputs, e.g., textual, details concerning the effects information represented by the displayed graphical marking 108.
• the interface screen 100 shown in FIG. 1 includes a details box 1 12 textually identifying details concerning the stimulation effects information of a selected one of the graphical markings 108.
• Such details can include the respective score(s) for therapeutic and/or adverse side effects and/or identifications of particular recorded therapeutic effects and/or side effects.
• a user can input specific therapeutic effects and/or adverse side effects produced by a stimulation using a particular set of stimulation parameters.
• the user can input data representing that a stimulation provides a therapeutic effect for one or more of rigidity, tremor, choking, bradykinesia, and/or other symptoms, and/or provides an adverse side effect such as, for example, one or more of parasthesia, dyskenisia, dystonia, etc.
• the user can input an overall therapeutic score and/or an overall adverse side effect score.
• the details box 1 12 shows that the selected map position (i.e., the stimulation parameters to which the selected map position corresponds) is associated with a recorded adverse side effect of dyskenisia, with an overall therapeutic effect score of 2, and an overall adverse side effect of 3.
• the details box 1 12 further identifies some of the stimulation parameters for which the clinical response information has been received.
• the details box 1 12 includes information regarding a single stimulation session.
• the details box 112 in FIG. 1 shows clinical response information obtained for a stimulation session that was performed on October 30, 2012, with a stimulation at an amplitude of 4.5mA, frequency of 120Hz, and pulse width of 60 ⁇ 8.
• the system further provides a session navigation control 115 for selecting different sessions, where, in response to a navigation instruction, input by a user using the navigation control 1 15 for navigating to a different session, the details box 1 12 is updated to reflect the information corresponding to the session to which the user has navigated.
• the details box 1 12 can include an "earlier" button and/or a "later” button, only the former being shown in FIG. 1, for changing the stimulation session whose details are displayed to either an earlier or later session than the one that is currently displayed.
• the graphical marking 108 is generated based on the information of all of the sessions (meeting any predefined or user-selected filter criteria), but the details box 112 shows the information of only one of the sessions at a time.
• a criteria selector control 1 10 is selectable by which to limit the sessions on which basis the characteristics of the graphical marking 108 are determined.
• One such filter is a history filter, by which the user can select a particular one or more sessions on which basis to generate the graphical marking 108, and therefore, the characteristics of the graphical marking 108 can reflect the information of the single session whose details are provided in the details box 112, even where information of other sessions and corresponding clinical response records are stored.
• the system and method display the map 102 in a touch-screen display, and the selection of a displayed graphical marking 108 can be by touch of the graphical marking 108.
• an input device such as predetermined keys of a keyboard, a joystick, or navigation pad is usable for moving between different points of the map 102, to select different ones of the graphical markings 108.
• the system and method display a cursor 120 for highlighting the currently selected graphical marking 108.
• the system and method provide for user input of new session data, including clinical response information, by interaction with the map 102 for updating the map 102.
• the user can move the cursor 120 to location of the map 102, for example, a location not currently populated with a graphical marking 108, input stimulation parameter information for the session, such as frequency and pulse width, and further input therapeutic and/or side effects information, for example, by selecting one or more of the therapeutic effect buttons 125 and/or one or more of the adverse side effect buttons 130.
• the buttons 125 and 130 include overall intensity indicator buttons 126 and 131 by which to input, respectively, a general level of therapeutic and/or adverse side effect.
• the intensity indicator buttons 126 and 131 can be used to input scores on a per effect basis to indicate a degree of the respective indicated effects.
• the buttons 125 and 130 include specific effect type indicator buttons 127 and 132 by which to input, respectively, particular types of therapeutic and/or adverse side effects associated with a session.
• FIG. 3 shows an example effect indicator menu screen 300 which includes additional buttons corresponding to respective therapeutic effects which the system and method display in response to selection of the "other" button 128, according to an example embodiment of the present invention.
• the map 102 is navigable between positions thereof.
• the system highlights the one or more of the buttons 125 and 130 that were previously selected to indicate clinical effect, in accordance with which selection(s) the graphical marking 108 was generated.
• the buttons that are highlighted are those selected for one of the sessions, e.g., whichever session is represented by the details box 1 12.
• information for a new session associated with electrode and amplitude settings corresponding to a position of the map 102 that is already populated with a graphical marking 108 can be input, based on which new input information, the graphical marking 108 can be updated.
• the system and method display a button by which a user can indicate that new session information is to be input.
• the system and method is configured to obtain other user input for entering a mode by which the user enters new session information.
• a user can choose whether to update information of a stimulation session for which clinical effect information had previously been recorded or to input information for an entirely new session.
• the details box 112 includes a button for updating a session whose details are displayed in the details box 1 12 and/or includes a button for input of new session information.
• the details box 112 includes a "delete" button for removing a clinical response record.
• a "delete" button for removing a clinical response record.
• the graphical marking 108 at a position is based on a single clinical response record that is being deleted, the graphical marking 108 is also responsively removed. If the graphical marking 108 is based on a number of stimulation response records, then the graphical marking 108 is updated to reflect removal of the effect thereon by the clinical response record being removed.
• a plurality of graphical markings 108 can overlap where clinical response information is recorded for settings that only slightly differ with respect to electrode location and/or amplitude setting.
• FIG. 1 shows a displayed user- interactive navigation pad 150 that includes a first section (shown in FIG. 1 to be represented by an up arrow) to shift the cursor 120 to a map position corresponding to a higher electrode position of the leadwire than to which the current map position of the cursor 120 corresponds; a second section (shown in FIG. 1 to be represented by a down arrow) to shift the cursor 120 to a map position corresponding to a lower electrode position of the leadwire than to which the current map position of the cursor 120 corresponds; a third section (shown in FIG.
• the pad 150 is a tool that provides the user with more control to fine tune the cursor position. According to an example embodiment, and as shown in FIG. 1, the system and method display in the navigation pad 150 a textual indication of the amplitude setting to which the current cursor location corresponds.
• the system and method provide, e.g., display, a step size control 151 by which the user can toggle between different step sizes, e.g., .1 and .5, by which each selection of the regions of the navigation pad 150 corresponding to amplitude effects the selected amplitude for repositioning of the cursor 120.
• a step size control 151 by which the user can toggle between different step sizes, e.g., .1 and .5, by which each selection of the regions of the navigation pad 150 corresponding to amplitude effects the selected amplitude for repositioning of the cursor 120.
• each selection of the '+' sign of the pad 150 is interpreted as an instruction to move the cursor 120 to a position of the map that corresponds to an amplitude setting that is .1 higher than that to which the current cursor position corresponds
• each selection of the '+' sign of the pad 150 is interpreted as an instruction to move the cursor 120 to a position of the map that corresponds to an amplitude setting that is .5 higher than that to which the current cursor position corresponds.
• selection of the '-' sign is interpreted as an instruction to move the cursor 120 to a position of the map that corresponds to an amplitude setting that is .1 or .5 (depending on the step size setting) lower than that to which the current cursor position corresponds.
• the cursor 120 can be dragged via a touchscreen.
• the user can touch any point in the map 102, responsive to which the system shifts the cursor 120 to the touched position of the map 102.
• the system and method output, e.g., display, toggle buttons 152 and 153 by which to toggle between different common settings for other stimulation parameters, such as frequency and pulse width. While such other parameters do not affect map position of the cursor 120 (in an embodiment in which the map 102 is two dimensional with one axis corresponding to electrode location and the other axis corresponding to amplitude), nevertheless the indicated values for such other parameters are, according to an example embodiment, indicated in the details box 112. Moreover, according to an example embodiment of the present invention, the selected values for such other parameters are used as filter criteria to filter the data on whose basis the clinical response map 102 is generated.
• the system For example, if the user selects a pulse width of 60 ⁇ 8 and a frequency of 125Hz, the system generates the graphical markings 108 based on only that data which corresponds to stimulations performed at those settings. According to an alternative example embodiment, the system does not use the parameters as filter criteria. According to an alternative example embodiment, the system is configured to obtain user input selecting whether to apply one or more of the settings as filter criteria for filtering the data on whose basis to generate the graphical markings 108. The selected parameter settings can similarly be used to filter the data used for generating other described aspects of the user interface, e.g., the records traversable using the session navigation control 1 15.
• the system and method display the clinical response map 102 overlapping an anatomical region representation 400 that graphically represents an anatomical region in which the leadwire is implanted.
• the anatomical region representation 400 is a silhouette of a head.
• Such an overlapping display can visually indicate how the electrodes location along the leadwire corresponds to the implant location.
• the system and method display a circle 405, centered on the electrode location to which the map position at which the cursor 120 is positioned corresponds and the outer perimeter of which passes through the map position at which the cursor 120 is positioned to provide the user with an indication of a relative magnitude of stimulation reach for the amplitude to which the cursor position corresponds.
• the value spacing is selected so that the size of the circle 405 corresponding to amplitude value approximately indicates an actual expected reach of produced electric field or tissue activation.
• the map 102 is usable for setting leadwire parameters to program an implanted pulse generator (IPG), for causing the leadwire to stimulate an anatomical region of a patient.
• IPG implanted pulse generator
• a user can navigate to a position in the map 102, which position corresponds to a particular electrode (actual or virtual) and amplitude setting, and can select a control interpreted by the system as an instruction to program the IPG accordingly. If frequency and pulse width values need to be changed, controls, for example as described above, can be used to modify the values of those parameters before input of the instruction to program the IPG.
• FIG. 1 shows the clinical response map 102 displayed in a same display screen as, and alongside, program panel 180 displaying information of a selected stimulation program.
• the program information is responsively updated in the program panel 180.
• the program panel 180 includes a stimulation application toggle button 182 to toggle between turning the program on and off.
• the system responsively programs the IPG with the stimulation parameters to which the selected position of the map 102 corresponds.
• the system includes one control for toggling between turning a stimulation program on and off and another control for selecting whether to apply settings to which the map position corresponds to the program.
• the IPG can be causing the leadwire to stimulate a tissue region according to the stimulation program which has been turned on. While the stimulation is ongoing, the user can use the map 102 to select new settings, and then select a button interpreted as an instruction to apply the new settings to the program currently being implemented.
• the system and method provide a program mode and a clinical response entry and viewing mode.
• the system and method display the graphical markings 108, and, in an example embodiment, show the details box 1 12 and highlight previously selected ones of the buttons 125 and/or 130 where such information is available for the selected position of the map 102.
• a map position is selectable in more than one way. If a first selection method is used, the details box 1 12 is displayed and if a second selection method is used, the program is set with the corresponding parameters. For example, cursor movement by drag or selection of a cursor movement input control can be used for changing program settings, and touch of a position can be used for viewing and/or updating clinical response information. Alternatively, the different selection methods can be left-click and right-click.
• More than one leadwire may be implanted in a patient. Additionally, a clinician may set up a number of programs to be implemented, for example, in a defined repetitive sequence, or at different predefined times or periods. Therefore, according to an example embodiment of the present invention, and as an example is shown in FIG. 1 , the system and method display a program selection panel 190 in which a plurality of defined programs are listed, where the program listings are selectable. In an example embodiment in which two leadwires are implanted, in response to selection of a program listing, the system and method responsively expands the program listing to display selectable listings of the left and right implanted leadwires. The program panel 180 is populated with information for the selected leadwire of the selected program.
• the map 102 can be used for selecting parameter values with which to set the right leadwire for program 1, and can be used for likewise selecting parameter values with which to set the left leadwire for program 1, and/or the right and/or left leadwires for other programs.
• the system and method display, for example in the program panel 180, baseline metrics concerning symptoms targeted to be treated by the stimulations.
• changes to such symptoms can be recorded over time in association with stimulation sessions, and the details box 1 12 shows the symptoms information recorded in association with the session whose details are displayed in the details box 112, to provide for easy comparison to the baseline symptoms.
• the system and method also displays a in the map 102 an umbrella graphical marking that spans many of the positions of the map 102, where a characteristic, e.g., color or color intensity, of the umbrella graphical marking gradually changes between positions of the map 102 based on the different clinical response data associated with different positions within the map 102.
• the system and method interpolates the clinical response data associated with different positions of the map 102 to obtain interpolated data for those positions not associated with clinical response data, thereby filling in the voids.
• the system and method display the umbrella graphical marking simultaneously with the graphical markings 108, and graphically demarcate the graphical markings 108 from the umbrella graphical marking.
• the graphical markings are outlined, e.g., with a black line, so that they stand out.
• the umbrella graphical marking is displayed using lighter shades of color than those used for the graphical markings 108, so that if, for example, a position of the map 102 is not associated with input clinical response data, but is assigned an interpolated clinical response value, the shade of color used at that position is softer than that used for a graphical marking 108 representing the same clinical response value.
• the system and method displays a first umbrella graphical marking representing the therapeutic effect data and a second umbrella graphical marking representing the adverse side effect data. Since they may be difficult to distinguish when they overlap each other, according to an example embodiment, the system and method provide a control by which the user can select which of the umbrella graphical markings to display, so that the user can thereby choose to display only one of them at a time.
• the system and method calculate an overall score based on both the therapeutic effect and adverse side effect information associated with the respective position, further calculate interpolated scores for the positions not associated with clinical response data, and output a single umbrella graphical marking based on the interpolated combinatory scores, which single umbrella marking gradually changes between positions according to the different scores, as described above.
• the system and method first generate interpolated scores separately for adverse side effects and therapeutic effects, and then calculate overall scores based on the interpolated scores to generate the single umbrella graphical marking.
• the system is configured to generate a report including information of previously implemented stimulation sessions according to user input filter criteria, where, for each particular row, all information used for generating the data of the respective row corresponds to use of the same electrode number (actual or virtual) and amplitude setting.
• the system is configured to generate, for each row for whose electrode number and amplitude value clinical response data is available, a respective graphical marking 108 as described above, and display the generated graphical marking 108 in a cell of the respective row. For example, the system generates the report with a column in which graphical markings 108 are displayed for those rows corresponding to an electrode and amplitude value for which clinical response data is available.
• FIG. 5 is an example report generated according to an example embodiment of the present invention.
• Column 1 500 includes graphical markings 108 for all of the populated rows except the second to last row which corresponds to an electrode and amplitude value for which no clinical responds data has been recorded.
• Stimulation parameters can be set by a clinician logging into a programming platform under a clinician profile, and can be set by a patient logging into the programming platform under a patient profile.
• a clinician may want to limit the amount of control the patient has over the stimulation settings.
• the clinician may determine that certain minimum and/or maximum amplitude levels must be met.
• the system is configured to receive input from a clinician of amplitude limits which the patient cannot violate.
• the system is configured to visually indicate such a limit(s) in the map 102.
• the system displays a line representing a maximum amplitude level and/or a line representing a minimum amplitude level extending perpendicular to the amplitude axis, and at respective positions along the amplitude axis, the respective positions corresponding to the respective maximum and/or minim amplitude values input by the clinician (or, in an example embodiment, default values if not altered or removed by the clinician).
• a line displayed at a first amplitude position and a second line displayed a second higher amplitude position would be recognized as corresponding to minimum and maximum values.
• the lines additionally otherwise graphically or textually indicate whether the line corresponds to a maximum or minimum.
• the line graphically or textually identifies whether the line represents a maximum or minimum limit. For example, text can be printed along the line to textually identify the line, or predefined colors and/or line forms (dashed, dotted, etc.) can be used.
• FIG. 6 shows an example system according to an example embodiment of the present invention.
• a system 600 includes a clinician and/or patient programmer terminal 605 that includes a telemetry module 606 and a user interface generation module 607.
• the telemetry module 606 is in communication with an implanted pulse generator (IPG) 610.
• IPG implanted pulse generator
• the user interface generation module 607 includes software executable by a processor for generating graphical user interface displays, as described above, for example, including code for generating the various described graphical markings and soft controls and for recording and displaying clinical effects information.
• interaction with one or more graphical user interface displays and/or a hardware input device is usable for input of one or more stimulation parameter settings in accordance with which the telemetry module 606 outputs instructions to the IPG 610, the IPG 610 accordingly controlling a leadwire 620 to activate one or more electrodes 621a-621g to produce electric pulses at specified amplitudes.
• the leadwire 620 is implanted in a patient, e.g., in the patient's brain, and the electric pulses are intended to activate anatomic fibers to produce a therapeutic effect, e.g., as described in further detail in the '330, '312, '340, '343, and '314 applications.
• the electrodes 621a-621g can include one or more directional electrodes which can be controlled to direct stimulation in a particular radial direction from the central longitudinal axis of the leadwire 620 and/or can include one or more cylindrical electrodes that produce essentially the same stimulation in all directions rotationally about the cylindrically symmetrical stimulation about the central longitudinal axis of the leadwire 620.
• the user interface displays provide for navigation of a clinical effects map to select the parameters for the instructions provided to the IPG 610.

Landscapes

• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Radiology & Medical Imaging (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Human Computer Interaction (AREA)
• User Interface Of Digital Computer (AREA)
• Electrotherapy Devices (AREA)

Priority Applications (3)

Applications Claiming Priority (4)

Publications (2)

Family

ID=50543688

Family Applications (1)

Country Status (5)

Cited By (1)

Families Citing this family (87)

Family Cites Families (130)

• 2014
  • 2014-03-14 WO PCT/US2014/028264 patent/WO2014144029A2/en not_active Ceased
  • 2014-03-14 EP EP14719164.7A patent/EP2968952B1/en active Active
  • 2014-03-14 US US14/212,730 patent/US9474903B2/en active Active
  • 2014-03-14 AU AU2014227964A patent/AU2014227964B2/en not_active Expired - Fee Related
  • 2014-03-14 JP JP2016502749A patent/JP6185142B2/ja not_active Expired - Fee Related

Also Published As

Similar Documents

Legal Events